Sunday November 22 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

PPL Therapeutics


Contact Details:
50 High View Lane, Suite 100
Mertztown
PA
19539
United States of America
Tel:610 682 0444
Fax:610 682 0557
Email:
WWW:

www.ppl-therapeutics.com/




Loading...

Recent Publications by PPL Therapeutics:

Nuclear equivalence, nuclear transfer, and the cell cycle.
The last 20 years have seen the development of techniques for the...
5th November, 2005
PPL Therapeutics, Cloning. 1999;1(1):3-15.
DOI Direct Link
Somatic cell nuclear transfer in mammals: progress and applications.
Somatic nuclear transfer has been performed with frogs since the early...
5th November, 2005
PPL Therapeutics, Roslin, Edinburgh EH25 9PP, Scotland. Cloning. 1999-2000;1(4):185-200.
DOI Direct Link
Analysis of telomere length in Dolly, a sheep derived by nuclear transfer.
We have used a (TTAGGG) oligonucleotide probe to demonstrate that ovine...
13th October, 2005
PPL Therapeutics, Roslin, Midlothian, Scotland. Cloning. 1999;1(2):119-25.
DOI Direct Link
Efficient production of transgenic cloned calves using preimplantation screening.
The genetic manipulation of donor cells before nuclear transfer (NT)...
22nd May, 2003
PPL Therapeutics Inc., Blacksburg, Virginia 24060, USA. Biol Reprod. 2002 Nov;67(5):1488-92.
Production of alpha 1,3-galactosyltransferase-deficient pigs.
The enzyme alpha1,3-galactosyltransferase (alpha1,3GT or GGTA1)...
6th February, 2003
PPL Therapeutics Inc., 1700 Kraft Drive, Blacksburg, VA 24060, USA. Science. 2003 Jan 17;299(5605):411-4. Epub 2002 Dec 19.
DOI Direct Link

View more PPL Therapeutics research publications.

Press Releases on PPL Therapeutics:

BioPortfolio Logo
Symphogen A/S Appoints Paul Rohricht As Vice President Of Business 1st June, 2005 Symphogen
Symphogen A/S Appoints Paul Rohricht As Vice President Of Business Development Copenhagen, Denmark (20 June 2005) – Symphogen A/S has named Paul Rohricht as Vice President of Business
PwC BioScience Index & Share League September - October 2002 1st November, 2002 Pwc
  PwC BioScience Index & Share League September - October 2002 The PwC BioScience Index highlights the performance of UK bioscience companies
DANIOLABS RAISES £850k IN SEED FUNDING TO ACCELERATE ITS  DRUG 1st October, 2001 Daniolabs
DANIOLABS RAISES £850k IN SEED FUNDING TO ACCELERATE ITS  DRUG DISCOVERY PROCESS 10th July 2002. DanioLabs
UK biotechs: biting off more than they can chew 1st January, 1970 Datamonitor
UK biotechs: biting off more than they can chew Five non-profitable UK biotech companies may be considering a merger, creating
Genovac Products for Drug Development in Japan 1st January, 1970 Genovac
  Genovac Products for Drug Development in Japan Freiburg/Yokohama (November 14, 2002) - Parallel to the rapid growth of the biotech

BioNews Results for PPL Therapeutics:

Astex Announces Strategic Drug Discovery Alliance with GlaxoSmithKline
PipelineReview:  Nov 15 2009 8:48PM Matching: therapeutics
EKR Therapeutics to Present at the Lazard Capital Markets 2009 Healthcare Conference
Pharma Live:  Nov 14 2009 10:40PM Matching: therapeutics
Esperion Therapeutics Initiates Phase I Clinical Study for ETC-1002
KOTA Territory News:  Nov 14 2009 11:05PM Matching: therapeutics
Esperion Therapeutics Initiates Phase I Clinical Study For ETC-1002
Medical News Today:  Nov 14 2009 10:16AM Matching: therapeutics
Esperion Therapeutics Initiates Phase I Clinical Study for ETC-1002
KSLA:  Nov 14 2009 7:29AM Matching: therapeutics
Promote your company here: BioNewsCast - Press Release Distribution

View more PPL Therapeutics news.

PPL Therapeutics Patents:

US Patent No.Title
7531715 Double nuclear transfer method and results thereof
5650503 Genetic construct of which protein coding DNA comprises introns and is designed for protein production in transgenic animals
5852224 .alpha.-lactalbumin gene constructs
5861299 Genetic construct of which protein coding DNA comprises introns and is designed for protein production in transgenic animals
5905185 Protein C production in non-human transgenic mammals

View more PPL Therapeutics patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 632 times since April 2007, the link to the organisation's website has been followed 117 times

Recent Search Terms used to find this page: ppl therapeutics | ppl therapeutics | PPL Therapeutics | PPL Therapeutics | PPL Therapeutics | ppl therapeutics | PPL Therapeutics company profile | PPL Th rapeutics | PPL Th rapeutics | PPL Th rapeutics | .

Search for more companies in Mertztown

Search for more companies in PA



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for PPL Therapeutics

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.